Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer

NCT04289779 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Cabozantinib
DRUG: Atezolizumab
PROCEDURE: Cystectomy

Sponsor

Deepak Kilari

Collaborators

[object Object]
[object Object]
[object Object]